03:33 PM EST, 02/18/2025 (MT Newswires) -- Health care stocks declined late Tuesday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both shedding 0.1%.

The iShares Biotechnology ETF (IBB) rose 0.4%.

In corporate news, Chimerix ( CMRX ) shares jumped 11% after the company said the US Food and Drug Administration has accepted its new drug application seeking accelerated approval for dordaviprone to treat recurrent H3 K27M-mutant diffuse glioma.